Universal Health Services, Inc. (NYSE:UHS) Q3 2021 Earnings Conference Call October 26, 2021 9:00 AM ET Company Participants Steve Filton - Chief Financial Officer Marc Miller - President Conference Call Participants Joanna Gajuk - Bank of America Marco Criscuolo - Nephron Research Andrew Mok - UBS Pito Chickering - Deutsche Bank Perry Wong - Wolfe Research Frank Morgan - RBC Capital Markets Ben Rossi - BMO Capital Markets A.J. Rice - Credit Suisse Jamie Perse - Goldman Sachs Whit Mayo - SVB Leerink Ralph G ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other ju ...

Universal Health Services, Inc. (NYSE:UHS) Q2 2021 Results Conference Call July 27, 2021 9:00 AM ET Company Participants Steve Filton - Chief Financial Officer Marc Miller - President Conference Call Participants Kevin Fischbeck - Bank of America Marco Criscuolo - Nephron Research Ralph Giacobbe - Citi Pito Chickering - Deutsche Bank Jamie Perse - Goldman Sachs Frank Morgan - RBC Capital Markets A.J. Rice - Crédit Suisse Operator Good day and thank you for standing by. Welcome to the Universal Health Servic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other j ...

Universal Health Services, Inc. (NYSE:UHS) Q1 2021 Earnings Conference Call April 27, 2021 9:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Marc Miller - President Conference Call Participants Perry Wong - Wolfe Research Kevin Fischbeck - Bank of America Ralph Giacobbe - Citi Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank A.J. Rice - Credit Suisse John Ransom - Raymond James Operator Good day and thank you for standing by. Welcome to the First Qu ...

Financial Data and Key Metrics Changes - The company reported net income attributable to UHS per diluted share of $3.60 for Q4 2020, with adjusted net income per diluted share at $3.59 [5] - Cash generated from operating activities was $2.36 billion in 2020, up from $1.438 billion in 2019 [12] - The ratio of debt to total capitalization decreased to 37.9% as of December 31, 2020, compared to 42% at the end of 2019 [13] Business Line Data and Key Metrics Changes - Approximately $316 million of revenues from governmental stimulus programs were attributed to acute facilities, while $97 million were from behavioral health facilities [7] - The company opened 439 new beds in existing hospitals and launched a new 102-bed hospital in Temple, Texas, along with three new freestanding emergency departments [14][15] Market Data and Key Metrics Changes - The company experienced a significant increase in COVID-19 patients in December 2020, impacting elective and scheduled procedures, leading to declines in both acute and behavioral patient days [11] - The company noted that emergency room volumes and elective procedures were down from pre-pandemic levels due to the presence of COVID patients [31] Company Strategy and Development Direction - The company plans to spend approximately $850 million to $1 billion on capital expenditures in 2021, including a new 170-bed acute care hospital in Reno, Nevada [16] - The company aims to resume its regular quarterly dividend and share repurchase program in 2021, pending Board approval [18] Management's Comments on Operating Environment and Future Outlook - Management expects COVID volumes to decline in 2021 as vaccines become more available, which should ease operational pressures and improve margins [19] - The company anticipates that the negative impact of COVID-19 will diminish throughout 2021, with a return to normal medical-surgical mix and increased behavioral patient base [32] Other Important Information - The company received approximately $417 million from governmental stimulus programs, which significantly impacted reported income [6] - An information technology incident in September 2020 had an unfavorable pre-tax impact of approximately $67 million due to lost revenues and recovery expenses [9] Q&A Session Summary Question: Margin compression despite revenue growth - Management explained that demand recovery is expected to outpace the easing of labor cost pressures, leading to margin compression in the first half of 2021 [22][23] Question: Capital expenditures across segments - Management highlighted significant capital spending on a new hospital in Reno and joint venture behavioral hospitals, indicating targeted investments in specific service lines and geographies [25][26] Question: Behavioral health market share - Management believes they have maintained market share despite challenges, attributing volume declines to COVID-related dynamics rather than loss of market position [36][40] Question: Impact of managed care negotiations - Management noted that revenue per adjusted day in behavioral health has increased due to less aggressive utilization management by insurers during the pandemic [58][60] Question: Deferred care and its impact - Management indicated that deferred care is expected to resurface as COVID volumes decline, with guidance assuming a return to pre-pandemic levels for elective procedures by the latter half of 2021 [110][111] Question: Las Vegas market recovery - Management expressed optimism about the Las Vegas market's recovery, noting that the gaming industry has begun to reopen and expand capacity [113][116]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or oth ...

Universal Health Services, Inc. (NYSE:UHS) Q3 2020 Earnings Conference Call October 30, 2020 10:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Alan Miller - Chairman & Chief Executive Officer Marc Miller - President Conference Call Participants Andrew Mok - Barclays Matthew Borsch - BMO Capital Markets Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Sarah James - Piper Sandler Pito Chickering - Deutsche Bank Ralph Giacobbe - Citi Josh Raskin - Nep ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other ju ...